Certara to Participate in Upcoming Investor Conferences
RADNOR, Pa. — 2024 年 8 月 21 日 -- Certara, Inc. （纳斯达克股票代码：CERT), a global leader in…
Certara2024 年 8 月 21 日
Quantitative Systems Pharmacology (QSP) Modeling for Immunotherapy-induced Cytokine Release Syndrome
Quantitative Systems Pharmacology (QSP) Modeling for Immunotherapy-induced Cytokine Release Syndrome
Cytokine Release Syndrome Cytokine release syndrome (CRS) is an inflammatory immune reaction that clinically manifests…
Certara2024 年 8 月 20 日
Navigating New Terrain: Joint Advice on FDA/EMA Compliance – Aligning with Evolving EU Regulations
Presentation Materials
Certara2024 年 8 月 20 日
Navigating New Terrain: The Impact of Evolving EU Regulations on Regulatory Affairs
Presentation Materials Don't miss Part 2 in the series Joint Advice on FDA/EMA Compliance…
Certara2024 年 8 月 20 日
Using Quantitative Systems Pharmacology (QSP) Modeling for Oncology Dose Optimization
The FDA’s Project Optimus initiative aims to reform dose optimization and selection for oncology therapies…
Certara2024 年 8 月 19 日
Automation in clinical trials: Why it’s essential for success
生命科学行业的许多公司在采用新技术方面进展缓慢。This is…
Certara2024 年 8 月 19 日
Subject Exposure in Aggregate Safety Reports & Common Issues
All new and existing drugs should be safe, effective, and efficacious for the treated populations.…
Certara2024 年 8 月 16 日
Certara Launches Phoenix™ Version 8.5 Drug Development Software
RADNOR, PA – 2024 年 8 月 15 日 - Certara, Inc. （纳斯达克股票代码：CERT), a global leader in…
Certara2024 年 8 月 15 日
Certara Research Reveals IRA’s Impact on Biosimilar Uptake
RADNOR, PA - 2024 年 8 月 15 日 -- Certara, Inc., a global leader in model-informed drug…
Certara2024 年 8 月 15 日
Mastering Value Storytelling in Healthcare: Leveraging Digital Tools to Meet Stakeholders’ Expectations
Everyone loves a good story. Stories are more likely to move and engage people than…
Certara2024 年 8 月 14 日
